Renato V. Iozzo, MD, PhD (honoris casusa)

Renato V. Iozzo, MD, PhD (honoris casusa)

Contact Dr. Iozzo

1020 Locust Street
336 JAH
Philadelphia, PA 19107

(215) 503-2208
(215) 923-7969 fax

Most Recent Peer-reviewed Publications

  1. Forced exercise-induced osteoarthritis is attenuated in mice lacking the small leucine-rich proteoglycan decorin
  2. The nature and biology of basement membranes
  3. A current view of perlecan in physiology and pathology: A mosaic of functions
  4. Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology
  5. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes
  6. Oncogenic activin C interacts with decorin in colorectal cancer in vivo and in vitro
  7. Glycoproteomics Reveals Decorin Peptides with Anti-Myostatin Activity in Human Atrial Fibrillation
  8. Endorepellin-evoked autophagy contributes to angiostasis
  9. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia
  10. Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions
  11. αvβ6 integrin promotes castrate-resistant prostate cancer through JNK1-mediated activation of androgen receptor
  12. Mechanisms of progranulin action and regulation in genitourinary cancers
  13. An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis
  14. Decorin as a multivalent therapeutic agent against cancer
  15. Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers
  16. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  17. EphA2 is a functional receptor for the growth factor progranulin
  18. Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin
  19. Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis
  20. Systemic delivery of an oncolytic adenovirus expressing decorin for the treatment of breast cancer bone metastases